These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21900152)

  • 1. Mathematically modelling the spread of hepatitis C in injecting drug users.
    Corson S; Greenhalgh D; Hutchinson S
    Math Med Biol; 2012 Sep; 29(3):205-30. PubMed ID: 21900152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users.
    de Vos AS; van der Helm JJ; Prins M; Kretzschmar ME
    Epidemics; 2012 Jun; 4(2):57-67. PubMed ID: 22664064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A time since onset of injection model for hepatitis C spread amongst injecting drug users.
    Corson S; Greenhalgh D; Hutchinson SJ
    J Math Biol; 2013 Mar; 66(4-5):935-78. PubMed ID: 22926752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology of HCV monoinfection and HIV/HCV coinfection in injection drug users in Liuzhou, Southern China.
    Tan Y; Wei QH; Chen LJ; Chan PC; Lai WS; He ML; Kung HF; Lee SS
    PLoS One; 2008; 3(10):e3608. PubMed ID: 18974888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nested-epidemic model for the spread of hepatitis C among injecting drug users.
    Esposito N; Rossi C
    Math Biosci; 2004; 188():29-45. PubMed ID: 14766092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New challenges for mathematical and statistical modeling of HIV and hepatitis C virus in injecting drug users.
    Kretzschmar M; Wiessing L
    AIDS; 2008 Aug; 22(13):1527-37. PubMed ID: 18670211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling the hepatitis C virus epidemic in Australia.
    Razali K; Thein HH; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M
    Drug Alcohol Depend; 2007 Dec; 91(2-3):228-35. PubMed ID: 17669601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs.
    Zeiler I; Langlands T; Murray JM; Ritter A
    Drug Alcohol Depend; 2010 Aug; 110(3):228-33. PubMed ID: 20430537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users.
    Roy E; Alary M; Morissette C; Leclerc P; Boudreau JF; Parent R; Rochefort J; Claessens C;
    Int J STD AIDS; 2007 Jan; 18(1):23-7. PubMed ID: 17326858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
    Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
    J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus among self declared non-injecting sexual partners of injecting drug users.
    Roy KM; Goldberg DJ; Hutchinson S; Cameron SO; Wilson K; MacDonald L
    J Med Virol; 2004 Sep; 74(1):62-6. PubMed ID: 15258969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users.
    Bowden S; McCaw R; White PA; Crofts N; Aitken CK
    J Viral Hepat; 2005 May; 12(3):322-4. PubMed ID: 15850474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficiency of targeted intervention in limiting the spread of HIV and Hepatitis C Virus among injecting drug users.
    De Vos AS; Kretzschmar ME
    J Theor Biol; 2013 Sep; 333():126-34. PubMed ID: 23733004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemic behavior of the hepatitis C virus.
    Pybus OG; Charleston MA; Gupta S; Rambaut A; Holmes EC; Harvey PH
    Science; 2001 Jun; 292(5525):2323-5. PubMed ID: 11423661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison between the force of infection estimates for blood-borne viruses in injecting drug user populations across the European Union: a modelling study.
    Sutton AJ; Hope VD; Mathei C; Mravcik V; Sebakova H; Vallejo F; Suligoi B; Brugal MT; Ncube F; Wiessing L; Kretzschmar M
    J Viral Hepat; 2008 Nov; 15(11):809-16. PubMed ID: 18761605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
    Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
    Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.